Guanze Medical (02427) and Funde (Hong Kong) Investment Holdings Announce Delay in Composite Document Dispatch

Bulletin Express03-04

Guanze Medical Information Industry (Holding) Co., Ltd. (Stock Code: 02427) and Funde (Hong Kong) Investment Holdings Co., Limited jointly announced a delay in the dispatch of their Composite Document related to a mandatory unconditional cash offer. The Composite Document, initially expected on or before 4 March 2026, has been deferred to a date on or before 10 April 2026.

The announcement states that additional time is required to prepare and finalize certain information, including the audited financial data for the year ended 31 December 2025. This information is targeted for publication by 31 March 2026. The executive arm of the relevant regulatory authority has indicated it is inclined to grant consent for the extended deadline.

Further updates will be released once the Composite Document and relevant acceptance forms are ready for dispatch or if the expected timeline changes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment